investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Drug Repositioning for Pharmacological Manipulation of p53 Family Members in p53 Mutant and Deficient Lung Tumors
Elsa Flores
2 Collaborator(s)
Funding source
University of Texas MD Anderson Cancer Center
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Joanna Zawacka-Pankau
Karolinska Institute
Stockholm, Sweden
Kristian Berg
University of Oslo
Oslo, Norway
Elsa Flores
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Jeffrey Schlom
Strategies for Cancer Vaccine Development: Preclinical Studies
Trachea, bronchus and lung
Pathology
Philip N. Tsichlis
Differential regulation of RNA processing by Akt isoforms
Trachea, bronchus and lung
Pathology
Joseph R Testa
RIP1/3 Kinases as New Targets in Malignant Mesothelioma
Trachea, bronchus and lung
Pathology
Jeffrey Schlom
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
Trachea, bronchus and lung
Pathology
Alan P Fields
Protein Kinase C Signaling Mechanisms in Cancer
Trachea, bronchus and lung
Pathology
Guanghua Xiao
Integrative Analysis to Identify Therapeutic Targets for Lung Cancer
Trachea, bronchus and lung
Pathology
Uwe Rix
Harnessing beneficial off-target effects of kinase inhibitors in lung cancer
Trachea, bronchus and lung
Pathology
Bakhos A Tannous
Detection of NSCLC-derived Mutant RNA in Platelets
Trachea, bronchus and lung
Pathology
Allan Balmain
The Role of the Kras4A Isoform in Epithelial Carcinogenesis
Trachea, bronchus and lung
Pathology
